Peer review reports
From: A single-arm confirmatory trial of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma: Japan Clinical Oncology Group study (JCOG1605, JCOG-PCAS protocol)
Original Submission |
3 Jun 2020 |
Submitted |
Original manuscript
|
1 Jul 2020 |
Author responded |
Author comments - Kohei Oashi
|
Resubmission - Version 2 |
1 Jul 2020 |
Submitted |
Manuscript version 2
|
Publishing |
2 Jul 2020 |
Editorially accepted |
|
13 Jul 2020 |
Article published |
10.1186/s12885-020-07136-1
|
Learn about peer review